Matthew Wright
Chief Operating Officer at Kinarus AG
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Alexander Bausch | M | - |
Kinarus AG
 Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | - |
| Silvio Inderbitzin | M | 59 |
Strekin AG
 Strekin AG BiotechnologyHealth Technology Strekin AG is a Swiss pharmaceutical company that develops pharmaceuticals, therapeutics, and vaccines. The private company was founded in 2014 and is based in Basel, Switzerland.
Kinarus AG
Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | - |
| Roger Meier | M | - |
Kinarus AG
Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | - |
| Hari Kumar | M | 69 |
Kinarus AG
Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | 3 years |
| Subhasis Roy | M | 55 |
Kinarus AG
Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | - |
| Thierry Fumeaux | M | - |
Kinarus AG
Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | 3 years |
| Eugene Tierney | M | - |
Kinarus AG
Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | - |
| Claudia Berger | F | - |
Kinarus AG
Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Nonis | M | - |
University of Maine
| 6 years |
| Jane L. Caron | F | - |
University of Maine
| 7 years |
| Andrew Frawley | M | 61 |
University of Maine
| 4 years |
| Michael W. Murphy | M | - |
University of Maine
| 3 years |
| Hugh Wight | M | - |
University of Maine
| 4 years |
| Dean H. Murray | M | - |
University of Maine
| 5 years |
| Ray Carter | M | - |
University of Maine
| 4 years |
| Joe A. Farrell | M | - |
University of Maine
| 3 years |
| Jon W. Chadbourne | M | - |
University of Maine
| 4 years |
| Charles N. Kasmer | M | - |
University of Maine
| 4 years |
| Wayne Steller | M | - |
University of Maine
| 4 years |
| Robert Hirshon | M | - |
University of Maine
| 5 years |
| Scott Upham | M | - |
University of Maine
| 4 years |
| John Beaupre | M | - |
University of Maine
| 4 years |
| Matthew L. Chase | M | - |
University of Maine
| 4 years |
| Barry Peters | M | - |
University of Maine
| 4 years |
| Kevin Blayne | M | - |
University of Maine
| 4 years |
| Gregory Porteous | M | - |
University of Maine
| 4 years |
| James M. Rice | M | - |
University of Maine
| 4 years |
| Mike A. Foisy | M | - |
University of Maine
| 4 years |
| James A. Montembeau | M | - |
University of Maine
| 4 years |
| Darryl Withrow | M | 59 |
University of Maine
| 4 years |
| Charles G. Bridge | M | 57 |
University of Maine
| 4 years |
| Brian Alan Bickford | M | - |
University of Maine
| 3 years |
| Scott P. Conners | M | 56 |
University of Maine
| 4 years |
| Glen Riley | M | 61 |
University of Maine
| 4 years |
| Jenifer Lynne Butler | F | - |
University of Maine
| 4 years |
| Clayton E. Andrews | M | 61 |
University of Maine
| 4 years |
| Paul Walsh | M | 59 |
University of Maine
| 4 years |
| Todd M. Pierce | M | - |
University of Maine
| 4 years |
| Scott Toothaker | M | 61 |
University of Maine
| 4 years |
| Bruce G. Nickerson | M | - |
University of Maine
| 3 years |
| Mark R. Stone | M | 61 |
University of Maine
| 4 years |
| Richard L. Mooers | M | 60 |
University of Maine
| 4 years |
| Michael Edward Barkley | M | - |
University of Maine
| 4 years |
| Robert Stolz | M | - |
University of Maine
| 4 years |
| Ralph S. Baker | M | - |
University of Maine
| 1 years |
| Jim Waltz | M | 54 |
University of Maine
| 4 years |
| Matthew McHatten | M | - |
University of Maine
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 39 | 82.98% |
| Switzerland | 8 | 17.02% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Matthew Wright
- Personal Network
